Prevention of noncommunicable diseases: Where we are and what’s next in the WHO European region?
- 16 December 2025
- journal article
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 53 (3_suppl) , 3-5
Abstract
Noncommunicable diseases (NCDs) account for the majority of mortality and morbidity in the World Health Organization (WHO) European region, largely driven by modifiable commercial determinants. Despite strong evidence supporting cost-effective interventions, implementation has been inconsistent due to industry interference, limited resources and policy inertia. To address this, WHO/Europe has identified a set of ‘quick buys’ capable of producing measurable health outcomes within 5 years. Experience shows that voluntary measures, pilot projects and the exchange of good practices alone are insufficient to achieve the 2030 Sustainable Development Goal (SDG) targets, making mandatory, well-enforced policies urgently needed to deliver the scale and speed of change required. As the 2030 SDG deadline approaches, accelerating policy action, strengthening surveillance systems and safeguarding public health governance from commercial interests are essential to reducing the NCD burden and achieving regional health targets.Keywords
Funding Information
- governments of Denmark, Estonia, Finland, France, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Norway, Slovenia and Sweden
This publication has 2 references indexed in Scilit:
- Quick buys for prevention and control of noncommunicable diseasesThe Lancet Regional Health - Europe, 2025
- Systematic review of the effect of policies to restrict the marketing of foods and non‐alcoholic beverages to which children are exposedObesity Reviews, 2022